Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group

A.A. Loosdrecht*, W. Kern, A. Porwit, P. Valent, S. Kordasti, E. Cremers, C. Alhan, C. Duetz, A. Dunlop, W. Hobo, F. Preijers, O. Wagner-Ballon, N. Chapuis, M. Fontenay, P. Bettelheim, L. Eidenschink-Brodersen, P. Font, U. Johansson, M.R. Loken, J.G. MarveldeS. Matarraz, K. Ogata, U. Oelschlaegel, A. Orfao, K. Psarra, D. Subira, D.A. Wells, M.C. Bene, M.G. Della Porta, K. Burbury, F. Bellos, V.H.J. van der Velden, T.M. Westers, L. Saft, R. Ireland

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Number of pages10
JournalCytometry Part B-clinical Cytometry
DOIs
Publication statusE-pub ahead of print - 13 Dec 2021

Keywords

  • consensus
  • ELN
  • flow cytometry
  • myelodysplastic syndromes
  • standardization
  • PROGNOSTIC SCORING SYSTEM
  • CLASSIFICATION
  • DIAGNOSIS
  • CYTOGENETICS
  • CELLS
  • STANDARDIZATION
  • CYTOMORPHOLOGY
  • VALIDATION
  • CONSORTIUM
  • SUBGROUPS

Cite this